Henlius

Shanghai Henlius Biotech is joint venture company that provides clinical-stage biopharmaceutical services.

Henlius, founded in February, 2010 and headquartered in Shanghai, is a medical company involved in tumors and autoimmune diseases. The founder is Chen Qiyu. Listed on the HKEX on September 25, 2019, the company's major shareholders are Shanghai Fosun New Medicine Research Co., Ltd., Henlius Biopharmaceuticals Inc. and Shanghai Fosun Pharmaceutical Industry Development Co., Ltd. Rivals that have direct and indirect competition with Henlius include Kintor, HitGen, Aprea Therapeutics, BridgeBio Pharma, etc.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Generic Pharma

Founded

Feb 24, 2010

HQ location

Shanghai, China

Legal name

Shanghai Henlius Biotech, Inc.

Employees

501-1000

See more